跳至主要内容
临床试验/KCT0007499
KCT0007499已完成未知

A 12 week, Randomized, Double-blind, Placebo-Controlled Clinical Trial for the Evaluation of the Efficacy and Safety of MC01 on the Skin Wrinkle Improvement and Moisturizing

Maeil Health Nutrition0 个研究点目标入组 100 人开始时间: 待定最近更新:
适应症

试验速览

阶段
未知
状态
已完成
发起方
入组人数
100

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional Study

入排标准

年龄范围
40(Year) 至 60(Year)(—)
性别
All

入选标准

  • 1) men and women between the ages of 40 and 60
  • 2) In visual assessment, Those with grade 3 or higher on both the left and right eye wrinkles
  • 3) Those with water retention of both cheeks measured with Corneometer® of 49 AU or less in visit 1and visit 2
  • 4) Befor Clinicla Trial, A person who agrees to participate in Clinical Trial, and write informed consent form.

排除标准

  • 1) Persons currently being treated for severe cardiovascular, immune, respiratory system, gastrointestinal/hepatic and biliary systems, kidney and urological systems, nervous system, musculoskeletal system, infectious diseases and malignancies
  • 2) A person with mental illness such as schizophrenia, depression, drug addiction, alcohol use/inducing disorder, etc
  • 3) People with skin diseases such as atopic dermatitis and psoriasis
  • 4) Those who have skin abnormalities such as spots, acne, erythema, capillary dilatation, etc. in the test area
  • 5) Smokers or persons less than one year after smoking cessation
  • 6) A person who has undergone a procedure such as Botox, filler, etc. on the face within 6 months of visit 1 or has undergone laser treatment, skin peeling, or other skin care on the face within 1 month (30 days)
  • 7) A person who has used a steroid-containing skin exoplasmic agent in the facial area or has taken an oral retinoid/steroid within 3 months of visit 1
  • 8) A person who has taken obesity treatments (fat absorption inhibitors, appetite suppressants, etc.), psychiatric drugs such as depression and schizophrenia, contraceptives or hormone drugs, or diuretics within one month of visit 1
  • 9) A person who has taken medicines and health functional foods (antioxidants, hyaluronic acid, collagen, moonflower seed oil, vitamins A, C, E-containing medicines and health functional foods) within 2 weeks of visit 1
  • 10) A person who has used functional cosmetics (retinoid agents, AHA, etc.), high-moisturizing cosmetics, or skin care devices (LED masks, ion boosters, etc.) to improve wrinkles within 2 weeks of visit 1
  • 11) A person with an AST (GOT) or ALT (GPT) of 120 IU/L or more or a ?-GTP of 180 IU/L or more
  • 12) A person who has a Creatine content of 2.4 mg/dL or more
  • 13) A Persons with TSH of 0.1 µIU/mL or Less or more than 10 µIU/mL
  • 14) an uncontrolled hypertensive patient(Systolic blood pressure greater than 160 mmHg or diastolic blood pressure greater than 100 mmHg, Measurement criteria after 10 minutes of stabilization)
  • 15) an uncontrolled diabetic(Not less than 180 mg/dL of fasting blood sugar)
  • 16) a pregnant or lactating woman or A person who has a pregnancy plan during this Clinical Trial period
  • 17) Those who have participated in other clinical trials within one month of visit 1 or who have plans to participate in other clinical trials since the start of this human application test
  • 18) A person who is sensitive or allergic to investigator's product and lactose for this Clinical Trial.
  • 19) A person who determines that the tester is unfit for other reasons

研究者

发起方
Maeil Health Nutrition

相似试验